Literature DB >> 24285042

Telomere length as a risk factor for hereditary prostate cancer.

Lauren M Hurwitz1, Christopher M Heaphy, Corinne E Joshu, William B Isaacs, Yuko Konishi, Angelo M De Marzo, Sally D Isaacs, Kathy E Wiley, Elizabeth A Platz, Alan K Meeker.   

Abstract

BACKGROUND: Telomeres are repetitive nucleotide sequences that stabilize the ends of chromosomes. Critically short telomeres are thought to contribute to cancer development by increasing chromosomal instability. We hypothesized that shorter leukocyte telomere length, a surrogate for inherited prostate cell telomere length, would be associated with increased risk of prostate cancer in hereditary prostate cancer (HPC) families.
METHODS: One hundred twelve affected and 63 unaffected men from 28 families were drawn from the Johns Hopkins HPC family database. Relative mean telomere length was measured in isolated peripheral leukocyte DNA by quantitative PCR. Conditional logistic regression was used to estimate the association between quartile of age-adjusted telomere length and prostate cancer.
RESULTS: Men in the shortest quartile of telomere length did not have increased odds of prostate cancer compared to men in the other three quartiles (OR = 0.84, 95% CI: 0.32-2.20, P = 0.73). However, when the analysis was restricted to affected men with blood drawn before or within a year of diagnosis (N = 39) and all unaffected men, shorter telomere length was moderately associated with increased odds of prostate cancer (OR = 3.55, 95% CI: 0.82-15.43, P = 0.09).
CONCLUSIONS: Though we found no association overall, shorter leukocyte telomere length may be associated with increased odds of prostate cancer when measured in pre-diagnostic samples. Further prospective research is warranted exploring the utility of telomere length as a prostate cancer biomarker.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  HPC families; prostate cancer risk; telomere biology

Mesh:

Year:  2013        PMID: 24285042      PMCID: PMC4479489          DOI: 10.1002/pros.22755

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

2.  Telomere length and possible link to X chromosome.

Authors:  Tim S Nawrot; Jan A Staessen; Jeffrey P Gardner; Abraham Aviv
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

3.  Telomere length predicts survival independent of genetic influences.

Authors:  Stephanie L Bakaysa; Lorelei A Mucci; P Eline Slagboom; Dorret I Boomsma; Gerald E McClearn; Boo Johansson; Nancy L Pedersen
Journal:  Aging Cell       Date:  2007-10-08       Impact factor: 9.304

4.  Telomere length and heredity: Indications of paternal inheritance.

Authors:  Katarina Nordfjäll; Asa Larefalk; Petter Lindgren; Dan Holmberg; Göran Roos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

Review 5.  Telomeres and human disease: ageing, cancer and beyond.

Authors:  Maria A Blasco
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

Review 6.  Human telomere biology: pitfalls of moving from the laboratory to epidemiology.

Authors:  Abraham Aviv; Ana M Valdes; Tim D Spector
Journal:  Int J Epidemiol       Date:  2006-09-22       Impact factor: 7.196

7.  Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.

Authors:  Alan K Meeker; Jessica L Hicks; Elizabeth A Platz; Gerrun E March; Christina J Bennett; Michael J Delannoy; Angelo M De Marzo
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

Review 8.  The complex genetic epidemiology of prostate cancer.

Authors:  Daniel J Schaid
Journal:  Hum Mol Genet       Date:  2004-01-28       Impact factor: 6.150

9.  Telomere length is paternally inherited and is associated with parental lifespan.

Authors:  Omer T Njajou; Richard M Cawthon; Coleen M Damcott; Shih-Hsuan Wu; Sandy Ott; Michael J Garant; Elizabeth H Blackburn; Braxton D Mitchell; Alan R Shuldiner; Wen-Chi Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-10       Impact factor: 11.205

Review 10.  Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.

Authors:  Alan K Meeker
Journal:  Urol Oncol       Date:  2006 Mar-Apr       Impact factor: 3.498

View more
  15 in total

1.  Evaluation of telomere length in human cardiac tissues using cardiac quantitative FISH.

Authors:  Maryam Sharifi-Sanjani; Alan K Meeker; Foteini Mourkioti
Journal:  Nat Protoc       Date:  2017-08-17       Impact factor: 13.491

2.  Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.

Authors:  Christopher M Heaphy; Michael C Haffner; Mindy K Graham; David Lim; Christine Davis; Eva Corey; Jonathan I Epstein; Mario A Eisenberger; Hao Wang; Angelo M De Marzo; Alan K Meeker; Tamara L Lotan
Journal:  Hum Pathol       Date:  2020-05-07       Impact factor: 3.466

3.  Minimal Shortening of Leukocyte Telomere Length Across Age Groups in a Cross-Sectional Study for Carriers of a Longevity-Associated FOXO3 Allele.

Authors:  Philip M C Davy; D Craig Willcox; Michio Shimabukuro; Timothy A Donlon; Trevor Torigoe; Makoto Suzuki; Moritake Higa; Hiroaki Masuzaki; Masataka Sata; Randi Chen; Rachel L Murkofsky; Brian J Morris; Eunjung Lim; Richard C Allsopp; Bradley J Willcox
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-10-08       Impact factor: 6.053

4.  Visualization of Telomere Integrity and Function In Vitro and In Vivo Using Immunofluorescence Techniques.

Authors:  Anthony J Cesare; Christopher M Heaphy; Roderick J O'Sullivan
Journal:  Curr Protoc Cytom       Date:  2015-07-01

5.  Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations.

Authors:  Kari A Weber; Christopher M Heaphy; Corinne E Joshu; Jiayun Lu; Sabine Rohrmann; Jessica L Bienstock; Tanya Agurs-Collins; Alan K Meeker; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2018-07-06       Impact factor: 2.506

6.  TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.

Authors:  Alexandra S Shadrina; Uljana A Boyarskikh; Natalja A Oskina; Tatiana V Sinkina; Alexandr F Lazarev; Valentina D Petrova; Maxim L Filipenko
Journal:  Tumour Biol       Date:  2014-10-10

7.  Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer.

Authors:  Benjamin A Rybicki; Sudha M Sadasivan; Yalei Chen; Ian Loveless; Nilesh S Gupta; Dhananjay A Chitale; Sean R Williamson; Andrew G Rundle; Deliang L Tang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-05-04       Impact factor: 4.090

8.  Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study.

Authors:  Chenan Zhang; Jennifer A Doherty; Stephen Burgess; Rayjean J Hung; Sara Lindström; Peter Kraft; Jian Gong; Christopher I Amos; Thomas A Sellers; Alvaro N A Monteiro; Georgia Chenevix-Trench; Heike Bickeböller; Angela Risch; Paul Brennan; James D Mckay; Richard S Houlston; Maria Teresa Landi; Maria N Timofeeva; Yufei Wang; Joachim Heinrich; Zsofia Kote-Jarai; Rosalind A Eeles; Ken Muir; Fredrik Wiklund; Henrik Grönberg; Sonja I Berndt; Stephen J Chanock; Fredrick Schumacher; Christopher A Haiman; Brian E Henderson; Ali Amin Al Olama; Irene L Andrulis; John L Hopper; Jenny Chang-Claude; Esther M John; Kathleen E Malone; Marilie D Gammon; Giske Ursin; Alice S Whittemore; David J Hunter; Stephen B Gruber; Julia A Knight; Lifang Hou; Loic Le Marchand; Polly A Newcomb; Thomas J Hudson; Andrew T Chan; Li Li; Michael O Woods; Habibul Ahsan; Brandon L Pierce
Journal:  Hum Mol Genet       Date:  2015-07-02       Impact factor: 6.150

9.  The association between telomere length and cancer risk in population studies.

Authors:  Xun Zhu; Wei Han; Wenjie Xue; Yuxia Zou; Cuiwei Xie; Jiangbo Du; Guangfu Jin
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

10.  Blood Telomere Length Attrition and Cancer Development in the Normative Aging Study Cohort.

Authors:  Lifang Hou; Brian Thomas Joyce; Tao Gao; Lei Liu; Yinan Zheng; Frank J Penedo; Siran Liu; Wei Zhang; Raymond Bergan; Qi Dai; Pantel Vokonas; Mirjam Hoxha; Joel Schwartz; Andrea Baccarelli
Journal:  EBioMedicine       Date:  2015-04-13       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.